Laurantis Pharma, Ltd. Report issue

For profit Phase 2
Founded: Turku Finland (2003)
Status: Acquired by Herantis Pharma Plc. (2014)

Organization Overview

First Clinical Trial
2011
NCT01476332
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

Key: Laurantis Pharma, Ltd. (0) Acquired (2)

cis-urocanic acid (3 trials)

tacrolimus (prograf) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 3
  • # of Trial APIs: 2